Brevianamide F is primarily studied for its biological activity, particularly its role as a secondary metabolite produced by certain fungal species. It has shown potential in antimicrobial and antifungal applications, making it of interest in the development of new agents to combat resistant microbial strains. Research also indicates neuroactive properties, with observed effects on neuronal signaling pathways, suggesting possible utility in neuroscience research or as a lead compound in neuropharmacology. Additionally, brevianamide F exhibits moderate cytotoxicity against select cancer cell lines, contributing to its evaluation in anticancer drug discovery efforts. Its complex indole alkaloid structure also makes it a target for synthetic studies aiming to develop novel derivatives with enhanced bioactivity.